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Phytosphingosine is abundant in plants and fungi and is found in mammalian epidermis, including the stratum
corneum. Phytosphingosine and its derivatives N-acetyl phytosphingosine and tetraacetyl phytosphingosine are
part of the natural defense system of the body. However, these molecules exhibit strong toxicities at high
concentrations. We synthesized phytosphingosine derivatives, mYG-II-6 ((Z)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydrox-
yoctadecan-2-yl)amino)but-2-enoic acid) and fYG-II-6 ((E)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)
amino)but-2-enoic acid), to increase efficacy and decrease toxicity, and the biological activities of the derivatives
in the inflammatory response were examined. Both YG-II-6 compounds effectively suppressed 12-O-tetradeca-
noylphorbol-13-acetate (TPA)–induced inflammatory skin damage and inflammatory response in a mouse model.
In addition, topical application of fYG-II-6 suppressed ear swelling and psoriasiform dermatitis in the ears of
IL-23-injected mice. Anti-inflammatory and antipsoriatic activities of the phytosphingosine derivatives inhibited
NF-kB, JAK/signal transducer and activator of transcription (JAK/STAT), and mitogen-activated protein kinase
(MAPK) signaling. Finally, the YG-II-6 compounds induced programmed cell death in keratinocytes and mouse
skin and were less toxic than phytosphingosine. Our study demonstrated that the phytosphingosine-derived
YG-II-6 compounds have much stronger biological potencies than the lead compounds. The YG-II-6 compounds
ameliorated inflammatory skin damage. Thus, YG-II-6 compounds are potential topical agents for treating chronic
inflammatory skin diseases, such as psoriasis.
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INTRODUCTION
The skin is the outermost organ of the human body and serves as
a primary wall-like barrier against environmental substances,
such as viruses, bacteria, UV radiation, toxic agents, injury, and
mechanical insults (Chuong et al., 2002; Tobin, 2006). The
outermost viable layer of the skin is the epidermis, which has a
highly active lipid-synthesizing tissue consisting of several
distinct layers. The stratum corneum is the outer layer of the
epidermis and is composed of corneocytes embedded in
lamellar lipid regions. The stratum corneum also contains
extracellular lipid membranes that are primarily composed of
cholesterol, free fatty acids, and ceramides with small amounts
of cholesterol esters and cholesterol sulfates (Coderch et al.,
2003). Most of these lipids are derived from the lamellar bodies
and synthesized in the keratinocytes of the upper stratum
spinosum and stratum granulosum. Lipid synthesis is very
active in the epidermis. The function of the skin as a protec-
tive barrier is regulated by synthesis of these lipids (Lee et al.,
2006; Feingold, 2009). Lipids are organized into broad lipid
bilayers in the intercorneocyte spaces. Mammalian skin lipid
bilayers play essential roles in preventing water loss and main-
taining moisture, maintaining a pliable skin barrier, and forming
a permeability barrier from the environment (Pappas, 2009).
Phytosphingosine and its derivatives are known to pre-
vent loss of moisture from the skin, regulate epidermal cell
growth, differentiation, and apoptosis, and possess bacter-
icidal and anti-inflammatory activities (Kim et al., 2003a, b,
2004, 2006; Pavicic et al., 2007; Fischer et al., 2012). Thus,
phytosphingosine and its derivatives are important for
maintaining healthy skin. The antibacterial and anti-
inflammatory activities of phytosphingosine were clearly
demonstrated in a clinical study in which acne patients
were treated with a variety of products such as skin and hair
conditioning agents that are currently used to treat acne
(Pavicic et al., 2007). Therefore, phytosphingosine and its
derivatives are associated with the natural defense system of
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the body. Although phytosphingosine and its derivatives
possess beneficial biological activities, these compounds
cannot be used at high concentrations because of toxic-
ities (Farwick et al., 2007; Snel et al., 2010; Song et al.,
2012).
In this study, we synthesized the phytosphingosine deriva-
tives, mYG-II-6 ((Z)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyocta-
decan-2-yl)amino)but-2-enoic acid) and fYG-II-6 ((E)-4-oxo-4-
(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic
acid), by combining phytosphingosine with either maleic
anhydride or (E)-4-ethoxy-4-oxobut-2-enoic acid to reduce
the toxicity and increase the biological activity of phyto-
sphingosine. We examined the anti-inflammatory activities of
these compounds in 12-O-tetradecanoylphorbol-13-acetate
(TPA)–induced human keratinocytes or cytokine-induced
human peripheral blood mononuclear cells (PBMCs),
mouse T cells, rat pre-T-lymphoma cells, and in cutaneous
inflammatory models in mice.
RESULTS
Spectral analysis
We synthesized two YG-II-6 compounds, mYG-II-6 and fYG-
II-6, from phytosphingosine and maleic anhydride or (E)-4-
ethoxy-4-oxobut-2-enoic acid (Figure 1a), respectively, as
described in the Materials and Methods section. The proton
nuclear magnetic resonance (1H-NMR) data for mYG-II-6
were 1H-NMR (DMSO-d6, 400 MHz) d 15.74 (s, 1H), 9.23 (br
s, 1H), 6.52 (br s, 1H), 6.24 (d, J¼ 12.7 Hz, 1H), 4.81 (d,
J¼ 6.0 Hz, 1H), 4.61 (s, 1H), 4.46 (d, J¼6.3 Hz, 1H),
4.13 4.05 (m, 1H), 3.71 3.63 (m, 1H), 3.563.49 (m,
1H), 1.561.36 (m, 2H), 1.32 1.14 (m, 24H), and
0.87 0.82 (m, 3H). The 1H-NMR data for fYG-II-6 were
1H-NMR (DMSO-d6, 400 MHz) d 12.75 (br s, 1H), 8.28 (d,
J¼ 8.8 Hz, 1H), 7.05 (d, J¼ 15.8 Hz, 1H), 6.50 (d, J¼ 15.4
Hz, 1H), 4.66 (d, J¼5.6 Hz, 1H), 4.54 (dd, J¼5.08,
5.16 Hz, 1H), 4.053.88 (m, 1H), 3.63 3.60 (m, 1H),
3.54 3.48 (m, 1H), 3.41 3.37 (m, 2H), 3.263.23 (m,
1H), 1.531.41 (m, 3H), 1.23 (s, 24H), and 0.85 (t, J¼ 6.2
Hz, 3H).
YG-II-6 compounds inhibit NF-jB signaling
We first examined NF-kB signaling because phytosphingosine
exhibits antiscratching, antimicrobial, and anti-inflammatory
activities in histamine- or TPA-induced mouse skin and human
skin (Kim et al., 2006; Pavicic et al., 2007; Ryu et al., 2010).
Both YG-II-6 compounds effectively inhibited phosphorylation
of IkBa and NF-kB p65 and degradation of IkBa in TPA-
stimulated human keratinocytes (Figure 1b). The YG-II-6
compounds also strongly inhibited NF-kB reporter activity
and nuclear translocation of NF-kB p65 in TPA-stimulated
keratinocytes (Figure 1c and d). In addition, we observed that
both YG-II-6 compounds significantly inhibited phosphoryla-
tion of IkBa and NF-kB p65 in mouse skin treated with a
double application of TPA. In contrast, the lead compounds,
including phytosphingosine, maleic anhydride, and fumaric
acid, exhibited weak or no inhibitory effects on NF-kB
signaling in TPA-induced keratinocytes and mouse skin
(Figure 1e).
YG-II-6 compounds inhibit JAK/STAT signaling
Phytosphingosine is a class of sphingolipids that regulate the T
cell–mediated immune response (Walsh et al., 2011; Paget
et al., 2012; Zygmunt et al., 2012). The cytokine-mediated
JAK/STAT signaling pathway also regulates the immune
response (Shuai and Liu, 2003). Thus, we examined whether
the YG-II-6 compounds could regulate JAK/STAT signaling.
Both YG-II-6 compounds inhibited phosphorylation of the JAK
and STAT proteins in TPA- or IFN-g-stimulated human
keratinocytes (Figure 2a). In addition, both compounds effec-
tively inhibited cytokine-induced phosphorylation of STAT1,
STAT3, and STAT5 in mouse T cells (Figure 2b and c) and
human PBMCs (Figure 2d and e).
Next, we assessed whether the YG-II-6 compounds inhib-
ited JAK2- or JAK-3-dependent STAT5 phosphorylation by
stimulating rat pre-T-lymphoma Nb2 cells with prolactin or
IL-2. Levels of phosphorylated JAK2/STAT5 and JAK3/STAT5
were dramatically increased in response to prolactin or IL-2,
whereas the YG-II-6 compounds decreased phosphorylated
JAK2/STAT5 and JAK3/STAT5 (Figure 2f). Thus, in addition to
inhibiting NF-kB signaling, the YG-II-6 compounds inhibited
JAK/STAT signaling more effectively than the lead compounds.
YG-II-6 compounds suppress cutaneous inflammation
Inhibition of NF-kB and JAK/STAT signaling suggests that the
YG-II-6 compounds may be effective therapies for inflamma-
tory and immune disorders. We examined acute irritant
contact dermatitis by applying TPA to the skin of mice to
determine if YG-II-6 compounds exhibit anti-inflammatory
activity in vivo. Increased skin thickness is the first hallmark
of skin irritation and local inflammation and is due to
increased vascular permeability, edema and swelling within
the dermis, and proliferation of epidermal keratinocytes (De
Vry et al., 2005; Kalyan Kumar et al., 2011). Epicutaneous
TPA application resulted in a marked increase in inflammatory
parameters, leading to increased skin thickness, edema and
swelling, vascular permeability, and epidermal cell
proliferation. Topical application of the YG-II-6 compounds
effectively decreased TPA-induced inflammatory parameters,
whereas the lead compounds exhibited weak to no inhibitory
effects on skin inflammation (Figure 3a–c). Similarly, a patch
test showed increased inflammatory parameters in the skin of
mice upon application of TPA, including increased skin
thickness, vascular permeability, and cell proliferation. In
contrast, these parameters were effectively suppressed by
fYG-II-6 application (Figure 3d).
Because topical application mainly affects the epidermis,
we also examined mRNA levels of proinflammatory mediators
in TPA-induced human keratinocytes. Similar to the histolo-
gical results, the mRNA levels of proinflammatory mediators,
including IL-1a, IL-6, IL-8, tumor necrosis factor–a, and
cyclooxygenase-2, were increased by TPA application. How-
ever, these levels were effectively suppressed by the YG-II-6
compounds. In contrast, the YG-II-6 compounds increased the
mRNA level of the anti-inflammatory cytokine IL-10. The anti-
inflammatory activities of the YG-II-6 compounds were more
effective than those of the lead compounds (Supplementary
Figure S1a online).
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The fYG-II-6 compound ameliorates psoriasiform dermatitis
In addition to the TPA-induced acute inflammatory model,
we assessed a chronic inflammatory model by intradermal
injection of IL-23 into the ears of mice (Zheng et al., 2007;
Rizzo et al., 2011; Maddur et al., 2012; Kim et al., 2013; Lee
et al., 2013). Intradermal IL-23 injection into mouse ear skin
induced psoriasiform dermatitis that leads to ear thickness,
edematous swelling, vascular permeability, and epidermal cell
proliferation. Topical application of fYG-II-6 suppressed these
inflammatory responses (Figure 4a and b).
Chemokine expression levels are controlled by proinflam-
matory mononuclear cells that are recruited to the inflamma-
tion site. fYG-II-6 effectively suppressed the mRNA levels of
chemokines and T helper type 17 cell cytokines, including
CXCL1, CCL17, CCL20, CCL27, IL-17A, and IL-22, that are
highly expressed in psoriasis (Harper et al., 2009; Mabuchi
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Figure 1. YG-II-6 compounds inhibit TPA-induced NF-kB signaling. (a) YG-II-6 compounds were synthesized from phytosphingosine and either fumaric acid ethyl
ester or maleic anhydride. (b) HaCaT cells were preincubated with compound for 1 hour and stimulated with TPA (100 nM). Western blot analysis was performed.
(c) NF-kB luciferase activity was measured in TPA-stimulated HaCaT cells. Results are shown as the mean± SEM. #Po0.001 versus empty vector-transfected
group, **Po0.001 versus NF-kB reporter-transfected group. (d) NF-kB nuclear translocation was examined in TPA-stimulated HaCaT cells. (e) Western blot
analysis was performed on the skin of C57BL/6 mice as described in the Materials and Methods. DMAP, 4-dimethylaminopyridine; EDCI, 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide; FA, fumaric acid ethyl ester; fYG-II-6, (E)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MA, maleic anhydride; mYG-II-6, (Z)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-
enoic acid; PS, phytosphingosine; TPA, 12-O-tetradecanoylphorbol-13-acetate.
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et al., 2011; Maeda et al., 2012). In addition, the mRNA levels
of proinflammatory mediators, such as IL-1a, IL-1b, IL-6,
IFN-g, and tumor necrosis factor-a, were also suppressed by
fYG-II-6 (Figure 4c). Similar to results obtained with TPA
stimulation, the mRNA levels of IL-10 were increased by fYG-
II-6 in IL-23-injected mouse ears (Figure 4c). IL-22 can also
induce psoriasiform dermatitis in a murine model and HaCaT
cells that express the IL-22 receptor (Mabuchi et al., 2012). The
mRNA levels of chemokines were not highly increased in IL-22-
stimulated HaCaT cells in comparison with IL-23-injected
mouse ears. However, fYG-II-6 significantly suppressed
mRNA expression levels of CXCL1, CXCL10, CCL17, CCL20,
and CCL27 (Supplementary Figure S1b online). These results
suggest that YG-II-6 compounds may be able to protect against
cutaneous inflammation resulting from acute irritant contact
dermatitis or chronic inflammatory diseases.
YG-II-6 compounds inhibit MAP kinases signaling
Mitogen-activated protein kinases (MAPKs) play key roles in
inflammatory signaling in mammalian cells (Johansen et al.,
2005; Wang et al., 2009). Generally, the extracellular signal–
regulated kinase pathway is involved in cell proliferation,
differentiation, and survival, whereas the p38 and JNK path-
ways are associated with apoptosis, inflammation, and
responses to environmental stress. In addition, extracellular
signal–regulated kinase and p38 signaling regulate NF-kB
signaling in various cell types (Matsumoto et al., 2000). We
observed that the YG-II-6 compounds effectively inhibited
phosphorylation of MAPKs, including extracellular signal–
regulated kinase 1/2, p38, and JNK in TPA-stimulated
keratinocytes (Figure 5). These results suggest that YG-II-6
compounds may regulate keratinocyte proliferation, survival,
apoptosis, and inflammation.
YG-II-6 compounds induce apoptosis
Because NF-kB, JAK/STAT, and MAPK signaling regulate cell
survival, we examined whether YG-II-6 compounds could
regulate cell proliferation and induce apoptosis. In previous
reports, phytosphingosine and its derivatives were cytotoxic
and induced apoptosis in keratinocytes and mouse skin (Kim
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Figure 2. YG-II-6 compounds inhibit JAK/STAT signaling. (a) HaCaT cells were stimulated with either TPA (400 nM) for 3 hours or IFN-g (200 U ml1) for
10 minutes followed by treatment with YG-II-6 compound for 1 hour. (b–e) Mouse T cells (b, c) or human PBMCs (d, e) were stimulated with IL-6 (10 ng ml 1),
IFN-g (200 U ml 1), or IL-2 (100 ng ml 1) for 10 minutes followed by treatment with YG-II-6 compound for 1 hour, respectively. (f) Rat pre-T-lymphoma Nb2 cells
were starved for 16 hours in the presence of DMSO or each compound and subsequently induced with either prolactin (PRL; 100 ng ml1) or IL-2 (100 ng ml 1)
for 10 minutes. Whole-cell extracts were subjected to western blot analysis with antibodies specific for the indicated molecules. fYG-II-6, (E)-4-oxo-4-(((2S,3S,4R)-
1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; mYG-II-6, (Z)-4-oxo-4-(((2S,3S,4R)-1,3,4-
trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; PBMC, peripheral blood mononuclear cell; STAT, signal transducer and activator of transcription;
TPA, 12-O-tetradecanoylphorbol-13-acetate.
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et al., 2003a, b, 2004). Phytosphingosine was more cytotoxic
than the YG-II-6 compounds and exhibited strong cytotoxic
activity at concentrations between 5 and 10mM. However,
maleic anhydride and fumaric acid did not exhibit cytotoxic
activities at concentrations as high as 2 mM (Figure 6a).
Western blots showed that the YG-II-6 compounds
increased expression of the proapoptotic proteins Bax and
Bad and induced fragmentation of the hallmark apoptotic
proteins, poly (ADP-ribose) polymerase and caspase 3. In
contrast, expression levels of cell cycle regulatory proteins
cyclin D1 and E, antiapoptotic protein B-cell lymphoma 2,
and cyclin-dependent kinases p21Cip/WAF1 and p27Kip1 were
decreased by YG-II-6 compounds in TPA-stimulated keratino-
cytes (Figure 6b).
Consistent results were observed by TUNEL assay in both
keratinocytes and mouse skin. The YG-II-6 compounds
increased the numbers of apoptotic cells in TPA-induced
primary and immortalized human keratinocytes (Figure 6c
and d) and in the skin of mice (Figure 6e). In comparison,
phytosphingosine weakly induced apoptosis, and maleic
anhydride and fumaric acid did not induce apoptosis in cells
or mouse skin (Figure 6).
DISCUSSION
Phytosphingosine is essential for healthy skin and helps to
regulate lipid production in the epidermal stratum corneum.
However, imbalances in the lipid constituents of the stratum
corneum leads to dry skin because of loss of moisture and can
cause skin diseases, such as psoriasis, atopic dermatitis,
eczema, ichthyosis, severe xerosis, and acne (Coderch et al.,
2003; Lee et al., 2006; Jungersted et al., 2008). The in vitro
and in vivo studies showed that phytosphingosine and its
derivatives exhibited biological activities, such as proliferation
and differentiation of keratinocytes, and provided skin care for
acne because of anti-inflammatory and antimicrobial activities
(Pavicic et al., 2007; Paragh et al., 2008). Thus,
phytosphingosine and its derivatives are potential cosmetic
or medicinal ingredients. In fact, fumaric acid esters, including
dimethyl fumarate, were developed for the treatment of
psoriasis by the German Chemist Schweckendiek in 1959
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Figure 3. YG-II-6 compounds suppress TPA-induced cutaneous inflammation in mouse skin. (a) TPA was applied to the dorsal skin of C57BL/6 mice (n¼ 6),
and skin biopsies were stained with hematoxylin and eosin (H&E). Scale bar¼ 100mm. (b, c) Epidermal thickness (b) and edema formation (c) were measured in
the skin of mice. Results are shown as the mean±SEM. #Po0.001 versus DMSO-treated group, and *Po0.05 and **Po0.005 versus TPA-treated group. (d) TPA
was topically administered to samples by transdermal patch for 24 hours, and skin biopsies were stained with proliferating cell nuclear antigen (PCNA) or H&E.
Scale Bar¼60mm. FA, fumaric acid ethyl ester; fYG-II-6, (E)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; MA, maleic anhydride;
mYG-II-6, (Z)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; PS, phytosphingosine; TPA, 12-O-tetradecanoylphorbol-13-acetate.
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and are known to have immunomodulatory, anti-
inflammatory, antiproliferative, and apoptotic actions (Seidel
et al., 2010; Wilms et al., 2010; Albrecht et al., 2012).
Therefore, fumaric acid esters and salts are potential
chemicals or drugs for treating adults with moderate to
severe plaque psoriasis (Ghoreschi et al., 2011; Heelan and
Markham, 2012) and granulomatous skin diseases, such as
granuloma annulare and cutaneous sarcoidosis (Kreuter et al.,
2002; Breuer et al., 2005). Fumaric acid esters and salts are
also currently being investigated as treatments for relapsing–
remitting multiple sclerosis (Moharregh-Khiabani et al., 2009;
Ghoreschi et al., 2011).
Although phytosphingosine and its derivatives have biolo-
gical activities, these compounds exhibit strong toxicities at
high concentrations. In addition, fumaric acid esters and their
salts have adverse effects, including diarrhea, abdominal pain,
facial flushing, renal damage, appetite, tiredness, leucopenia,
lymphopenia, transient eosinophilia, and spontaneous persis-
tent erythema. We synthesized the phytosphingosine deriva-
tives, mYG-II-6 and mYG-II-6, to reduce toxicity and increase
efficacy. The biological and pharmacological activities of
these derivatives were examined in TPA-induced human
keratinocytes and animal models of skin inflammation
induced by TPA or IL-23 stimulation.
Keratinocytes are major cells in the epidermis of the skin
and play important roles in protecting the body from environ-
mental stimuli and skin inflammation (Pivarcis et al., 2005).
We found that YG-II-6 compounds were less cytotoxic and
induced more apoptotic cell death compared with
phytosphingosine in human keratinocytes and mouse skin by
regulating proapoptotic proteins, cell cycle regulators, and
antiapoptotic proteins. These data suggest that YG-II-6
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Figure 4. YG-II-6 ((E)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid) compound ameliorates IL-23-induced psoriasiform
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compounds can regulate physiological processes that promote
tissue development in the skin with reduced cytotoxicity.
YG-II-6 compounds inhibited the NF-kB, JAK/STAT, and
MAPK signaling in TPA- or cytokine-induced human kerati-
nocytes, human PBMCs, mouse T cells, and rat pre-T-lym-
phoma cells. NF-kB and STAT proteins are transcription
factors, and MAPKs are serine/threonine-specific protein
kinases that play important roles in immune and inflammatory
responses. However, aberrantly activated these signaling
cascades are important therapeutic targets in inflammatory
diseases and cancer (Mudter and Neurath, 2003; Shuai and
Liu, 2003; Brown et al., 2008; Sarkar et al., 2008; Lawrence,
2009; Sikorski et al., 2011). Phytosphingosine and its
derivatives inhibit NF-kB and MAPK signaling (Kim et al.,
2003b; Park et al., 2003; Ryu et al., 2010), whereas their
effects on JAK/STAT signaling have not yet been reported.
We observed that YG-II-6 compounds effectively inhibited
the NF-kB and JAK/STAT signaling cascades in TPA- or
cytokine-stimulated keratinocytes, human PBMCs, mouse
T cells, and TPA-induced mouse skin. These inhibitory activi-
ties were much stronger than those of the lead compounds,
phytosphingosine, maleic anhydride, and fumaric acid. The
inhibitory activities of phytosphingosine and its derivatives
on JAK/STAT signaling are unreported findings. Furthermore,
the inhibitory activities of the derivatives were much stronger
than those of the lead compounds in all of the cells that were
tested.
Application of these derivatives as biologically active
medicines and cosmetic ingredients may be important
for skin care, because phytosphingosine and its derivatives
have recently been sold in cosmetic markets. Although
phytosphingosine exhibited beneficial effects in cosmetic
markets, topical application at high doses is limited because of
high toxicity. Several researchers modified and developed
phytosphingosine derivatives to reduce toxic effects, and they
examined the biological activities of these compounds
(Kim et al., 2003a, b, 2004, 2006; Park et al., 2003; Pavicic
et al., 2007; Ryu et al., 2010; Walsh et al., 2011; Paget et al.,
2012; Zygmunt et al., 2012). The biological and
pharmacological activities of YG-II-6 compounds were
tested in an animal model, in which skin inflammation was
induced by topical application of TPA or intradermal injection
of IL-23 in mouse skin. Topical application of TPA induces IL-
1a-mediated acute and chronic inflammation and hyperplasia
in mouse skin (Lee et al., 1994). In addition, intradermal IL-23
injection into the ears of mice induces chronic inflammation
(Zheng et al., 2007; Rizzo et al., 2011; Maddur et al., 2012;
Kim et al., 2013; Lee et al., 2013). These stimuli induce
inflammatory responses in the skin that increase dermal
edematous swelling, erythema, leukocyte infiltration, epider-
mal hyperplasia, and proliferation of epidermal keratinocytes.
YG-II-6 compounds significantly suppressed progression of
inflammatory skin damage in the skin and ears of mice. In
addition to suppressing skin damage, YG-II-6 compounds
significantly suppressed the expression of proinflammatory
mediators, such as enzymes, cytokines, and chemokines,
whereas the expression of anti-inflammatory cytokine IL-10
was markedly increased.
In conclusion, we determined biological and pharmacolo-
gical activities of the phytosphingosine derivatives, mYG-II-6
and fYG-II-6. Both YG-II-6 compounds exhibited effective
anti-inflammatory activities and therapeutic effects in TPA- or
cytokine-stimulated keratinocytes, human PBMCs, mouse T
cells, and in cutaneous inflammatory models. The potencies of
these compounds were much stronger than those of the lead
compounds, phytosphingosine, maleic anhydride, and fuma-
ric acid. The biological activities of YG-II-6 compounds were
associated with inhibition of the NF-kB, JAK/STAT, and MAPK
signaling with induction of programmed cell death. Inhibition
of JAK/STAT signaling by these phytosphingosine derivatives
is an unreported finding. Our data suggest that YG-II-6
compounds are promising candidates for the treatment of
acute and chronic inflammatory skin diseases and potential
ingredients for cosmetic skin care agents.
MATERIALS AND METHODS
Isolation of human PBMCs and mouse T cells
This study was conducted according to the Declaration of Helsinki
Principles and was approved by the institutional review board (IRB) of
The Catholic University of Korea (KC12TISI0433). We obtained human
blood samples from 3 male healthy donors aged from 27 to 43 years
with their written informed consent. The donors did not take any
therapy and were not hospitalized for at least 6 months. PBMCs were
isolated from heparinized blood samples by density gradient centrifu-
gation using Ficoll-Paque PLUS (GE Healthcare Bio-Sciences, Uppsala,
Sweden). Cells collected from interface were washed with phosphate-
buffered saline and maintained in RPMI-1640 medium supplemented
with 10% fetal bovine serum and antibiotics. Mouse T cells were
isolated from spleens and lymph nodes of C57BL/6 mice as described
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Figure 5. YG-II-6 compounds inhibit TPA-induced MAPK signaling. HaCaT
cells were pretreated with compounds and then stimulated with TPA for
15 minutes. Western blot analysis was performed with primary antibodies
against the target molecules. ERK1/2, extracellular signal–regulated kinase 1/2;
FA, fumaric acid ethyl ester; fYG-II-6, (E)-4-oxo-4-(((2S,3S,4R)-1,3,4-
trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; MA, maleic anhydride;
MAPK, mitogen-activated protein kinase; mYG-II-6, (Z)-4-oxo-4-(((2S,3S,4R)-
1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; PS, phytosphingosine;
TPA, 12-O-tetradecanoylphorbol-13-acetate.
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Figure 6. YG-II-6 compounds induce apoptosis in cells and mouse skin. (a) HaCaT cells were incubated in the presence of DMSO or compound for 24 hours,
and cell viability was measured with WST-1 reagent. Results are shown as the mean±SEM. **Po0.001 versus DMSO-treated group. (b) Western blot analysis
was performed on lysates from HaCaT cells incubated with TPA in the presence of DMSO or compound for 24 hours. (c, d) Primary human keratinocytes
(c) or HaCaT cells (d) were incubated with the above mentioned, and TUNEL assay was performed. (e) Dorsal skins of C57BL/6 mice were prepared as mentioned
in Figure 3a, and apoptotic cell death was visualized by FITC-stained TUNEL assay. Nuclei were counterstained with DAPI. Bcl-2, B-cell lymphoma 2; DAPI, 4’,
6-diamidino-2-phenylindole; FA, fumaric acid ethyl ester; fYG-II-6, (E)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; MA, maleic anhydride; mYG-II-6, (Z)-4-oxo-4-(((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)amino)but-2-enoic acid;
PARP, poly (ADP-ribose) polymerase; PS, phytosphingosine; TPA, 12-O-tetradecanoylphorbol-13-acetate.
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previously and maintained in RPMI-1640 medium supplemented with
10% fetal bovine serum and antibiotics (Kim et al., 2013).
Cell culture
The immortalized human keratinocyte HaCaT cells were purchased
from CLS Cell Line Service (Eppelheim, Germany) and maintained in
DMEM supplemented with 10% fetal bovine serum and antibiotics.
The human keratinocytes were isolated from the skin of healthy
volunteers using a keratinocyte primary isolation kit (Cascade
Biologics, Portland, OR) and cultured as described previously (Kim
et al., 2011). Rat pre-T lymphoma Nb2 cells (kindly provided by Dr
Charles Clevenger, Northwestern University, Evanston, IL) were
cultured in RPMI-1640 supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 5 mM HEPES (pH 7.4), and antibiotics.
Western blot analysis
Protein levels were analyzed by western blot analysis with specific
primary antibodies for the target molecules, followed by appropriate
horseradish peroxidase–conjugated secondary antibodies (Invitrogen,
Grand Island, NY).
Quantitative real-time PCR
Total RNA was isolated using TRIzol Reagent (Ambion, Carlsbad,
CA). The complementary DNA synthesis and quantitative real time-
PCR were performed as described previously (Kim et al., 2011).
Transfection and NF-jB reporter assay
HaCaT cells were transfected with plasmids containing both NF-kB-
luciferase construct and pRL-TK vector using Effectene Transfection
Reagent (Qiagen, Hilden, Germany) and the luciferase activity was
measured using a Dual-Luciferase Assay kit (Promega, Sunnyvale, CA)
as described previously (Kim et al., 2011).
Cell viability assay and TUNEL staining
Cells were seeded into 96-well plate at a density of 20,000 cells per
well. After overnight, the cells were incubated with either compound
or vehicle for 24 hours, and cell viability was determined using EZ-
CyTox Enhanced Cell Viability Assay Kit (Daeil Lab Service, Seoul,
Korea) according to the manufacturer’s protocols. For performing
TUNEL assay, samples were stained using an In Situ Apoptosis
Detection Kit (Clontech, Mountain View, CA) to detect in situ DNA
fragmentation according to the manufacturer’s protocol, and FITC
signals were visualized with a confocal Laser Scanning Microscopy
(Carl Zeiss, Oberkochen, Germany).
Histological and immunohistochemical analysis
Skin samples were fixed with 4% paraformaldehyde in phosphate-
buffered saline for 24 hours, washed with tap water, dehydrated with
grade ethanol, and then embedded in paraffin. Then, 5mm sections
were mounted on glass slides, dewaxed, rehydrated with grade
ethanol, and stained with hematoxylin and eosin. For immunohisto-
chemical analysis, deparaffinized sections were removed endogenous
peroxidase, blocked, and then incubated with proliferating cell
nuclear antigen antibody. The sections were labeled with biotin–
streptavidin–immunoperoxidase complex, developed with diamino-
benzidine (Dako, Carpinteria, CA), and counterstained with 0.2%
Mayer’s hematoxylin (Sigma-Aldrich, St Louis, MO). Analysis was
carried out using an inverted fluorescence microscope (Carl Zeiss).
TPA-induced cutaneous inflammation model
The protocol for animal use was approved by The Catholic Research
Institute of the Medical Science Committee on Institutional Animal
Care and Use. Cutaneous inflammation was induced by double TPA
treatment as reported previously (Ha et al., 2006). The mice were
killed 1 hour after the second TPA application and the dorsal skins of
mouse were collected for further experiments. Another cutaneous
inflammatory model was performed by patch test. Tape stripping was
performed with a 3 mm Tegaderm Film (6 7 cm, 3M Health Care,
Neuss, Germany). TPA was applied on the back of hairless mouse in
the presence or absence of fYG-II-6 for 24 hours, and the skins of
mice were collected for further experiments.
IL-23-induced psoriasis-like model
Phosphate-buffered saline or recombinant mouse IL-23 (500 ng per
10ml, eBioscience, San Diego, CA) was intradermally injected into
C57BL/6 mouse ears, followed by topical application of compounds
every other day for 14 days as described previously (Kim et al., 2013;
Lee et al., 2013). Ear thickness was measured 24 hours after final
injection and the ears were collected for further experiments.
Statistical analysis
Results in figures were represented as mean±SEM. Statistical analysis
of differences among groups was determined by Student’s t-test.
Differences were considered statistically significant at a level of
*Po0.05 and **Po0.001.
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